The alteration of plasma TGF-β1 levels in patients with brain tumors after tumor removal

Transforming growth factor (TGF) β1 may be a candidate for a serologic tumor marker. In this study, the plasma levels of TGF-β1 in patients with brain tumors were measured using enzyme-linked immunosorbent assay before and after tumor removal. Patients were divided into four groups, the control grou...

Full description

Bibliographic Details
Main Authors: Joon-Khim Loh, Ann-Shung Lieu, Yu-Feng Su, Chi-Yun Cheng, Tai-Hsin Tsai, Chih-Lung Lin, Kung-Shing Lee, Shiuh-Lin Hwang, Aij-Lie Kwan, Chih-Jen Wang, Yi-Ren Hong, Shen-Long Howng, Chung-Ching Chio
Format: Article
Language:English
Published: Wiley 2012-06-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X11002671